ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 49 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q2 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $2,666 | -31.5% | 23,000 | 0.0% | 0.00% | – |
Q4 2022 | $3,894 | -22.1% | 23,000 | 0.0% | 0.00% | – |
Q3 2022 | $5,000 | -58.3% | 23,000 | 0.0% | 0.00% | -100.0% |
Q2 2022 | $12,000 | -7.7% | 23,000 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $13,000 | -7.1% | 23,000 | 0.0% | 0.00% | -50.0% |
Q4 2021 | $14,000 | -36.4% | 23,000 | 0.0% | 0.00% | -50.0% |
Q3 2021 | $22,000 | -12.0% | 23,000 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $25,000 | +13.6% | 23,000 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $22,000 | +100.0% | 23,000 | 0.0% | 0.00% | +100.0% |
Q4 2020 | $11,000 | -38.9% | 23,000 | 0.0% | 0.00% | -60.0% |
Q3 2020 | $18,000 | +50.0% | 23,000 | 0.0% | 0.01% | +66.7% |
Q2 2020 | $12,000 | +50.0% | 23,000 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $8,000 | -50.0% | 23,000 | 0.0% | 0.00% | -50.0% |
Q4 2019 | $16,000 | 0.0% | 23,000 | 0.0% | 0.01% | 0.0% |
Q3 2019 | $16,000 | -46.7% | 23,000 | 0.0% | 0.01% | -60.0% |
Q2 2019 | $30,000 | -38.8% | 23,000 | 0.0% | 0.02% | -44.4% |
Q1 2019 | $49,000 | – | 23,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BARD ASSOCIATES INC | 124,300 | $87,000 | 0.04% |
Hayden Royal, LLC | 16,000 | $12,272,000 | 0.01% |
Global Strategic Investment Solutions, LLC | 23,000 | $16,000 | 0.01% |
Founders Capital Management | 8,000 | $6,000 | 0.01% |
Cable Hill Partners, LLC | 20,000 | $14,000 | 0.00% |
Jacobi Capital Management LLC | 25,000 | $18,000 | 0.00% |
Stonebridge Capital Advisors LLC | 22,000 | $15,000 | 0.00% |
B. Riley Wealth Advisors, Inc. | 37,520 | $27,000 | 0.00% |
Firestone Capital Management | 5,200 | $4,000 | 0.00% |
MGO ONE SEVEN LLC | 10,615 | $7,000 | 0.00% |